Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Reimbursement for AI-based plaque assessments is improving
A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen.
Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs
The timing of this new guidance from the Heart Rhythm Society and American College of Cardiology could not have been better—the document went live just as CMS finalized its decision to cover cardiac ablation procedures performed in ASCs.
IVC filter recalled due to injury risk
Customers are urged to stop using these devices right away.
FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.

heart data research doctor cardiologist AI

New-onset AFib is common after CABG—but typically not persistent or symptomatic

The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

Field Medical FieldForce Ablation pulsed field ablation

Field Medical’s PFA system for ventricular tachycardia shows early potential

More research is still required, but Field Medical's FieldForce Ablation System may represent a significant step forward in the treatment of scar-related ventricular tachycardia.

James Muller, MD, explains advances in vulnerable plaque imaging aim to predict and prevent heart attacks.

Advances in imaging could help predict, prevent heart attacks

Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.

Medtech companies working together on robotic PFA system

Stereotaxis and CardioFocus are collaborating on a new robotic pulsed field ablation system. After completing some initial research, the companies are now working toward the launch of a clinical trial.

Marcelo Di Carli, MD, editor-in-Chief of the Journal of Nuclear Cardiology, chief, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, and executive director, Cardiovascular Imaging Program, at Brigham and Women's Hospital, explains why there is rapid growth of PET imaging because of the extra value it brings in detecting microvascular disease.

How PET is transforming cardiac nuclear imaging

"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology," Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.

Cardiologists perform first TTVR of its kind on recent heart transplant recipient

When a 50-year-old patient developed severe TR just months after receiving a heart transplant, the safest treatment option was to implant an Evoque TTVR device.

Q&A: What cardiologists know and don’t know about pulsed field ablation

Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.

FDA details Class I recalls for more than 1 million pacemakers—software update required

The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.

Cardiac Imaging

Reimbursement for AI-based plaque assessments is improving

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs

IVC filter recalled due to injury risk

FDA clears TAVR guidewire built with BASILICA in mind